These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24173169)

  • 1. From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment.
    MacKay C; Davies M; Summerfield V; Maxwell G
    ALTEX; 2013; 30(4):473-86. PubMed ID: 24173169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.
    Maxwell G; MacKay C; Cubberley R; Davies M; Gellatly N; Glavin S; Gouin T; Jacquoilleot S; Moore C; Pendlington R; Saib O; Sheffield D; Stark R; Summerfield V
    Toxicol In Vitro; 2014 Feb; 28(1):8-12. PubMed ID: 24184331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adverse outcome pathway for skin sensitisation: Moving closer to replacing animal testing.
    Schultz TW; Dimitrova G; Dimitrov S; Mekenyan OG
    Altern Lab Anim; 2016 Oct; 44(5):453-460. PubMed ID: 27805828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
    Roberts DW; Patlewicz G
    J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probabilistic hazard assessment for skin sensitization potency by dose-response modeling using feature elimination instead of quantitative structure-activity relationships.
    Luechtefeld T; Maertens A; McKim JM; Hartung T; Kleensang A; Sá-Rocha V
    J Appl Toxicol; 2015 Nov; 35(11):1361-1371. PubMed ID: 26046447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of peptide reactivity assays for skin sensitisation hazard identification and risk assessment.
    Gerberick GF
    Altern Lab Anim; 2016 Oct; 44(5):437-442. PubMed ID: 27805826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a defined approach based on a stacking prediction model to identify skin sensitization hazard.
    Tourneix F; Alépée N; Detroyer A; Eilstein J; Martinozzi Teissier S; Nardelli L; Noçairi H; Pauloin T; Piroird C; Del Bufalo A
    Toxicol In Vitro; 2019 Oct; 60():134-143. PubMed ID: 31100378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro testing strategy for assessing the skin sensitizing potential of "difficult to test" cosmetic ingredients.
    Bergal M; Puginier M; Gerbeix C; Groux H; Roso A; Cottrez F; Milius A
    Toxicol In Vitro; 2020 Jun; 65():104781. PubMed ID: 32001296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Spectro-DPRA, KeratinoSens™ and h-CLAT to estimation of the skin sensitization potential of cosmetics ingredients.
    Cho SA; Choi M; Park SR; An S; Park JH
    J Appl Toxicol; 2020 Feb; 40(2):300-312. PubMed ID: 31680285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 21st Century movement within the area of skin sensitization assessment: From the animal context towards current human-relevant in vitro solutions.
    de Ávila RI; Lindstedt M; Valadares MC
    Regul Toxicol Pharmacol; 2019 Nov; 108():104445. PubMed ID: 31430506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies.
    Ezendam J; Braakhuis HM; Vandebriel RJ
    Arch Toxicol; 2016 Dec; 90(12):2861-2883. PubMed ID: 27629427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer models versus reality: how well do in silico models currently predict the sensitization potential of a substance.
    Teubner W; Mehling A; Schuster PX; Guth K; Worth A; Burton J; van Ravenzwaay B; Landsiedel R
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):468-85. PubMed ID: 24090701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice.
    Jaworska J; Dancik Y; Kern P; Gerberick F; Natsch A
    J Appl Toxicol; 2013 Nov; 33(11):1353-64. PubMed ID: 23670904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The skin sensitization adverse outcome pathway: exploring the role of mechanistic understanding for higher tier risk assessment.
    Aleksic M; Rajagopal R; de-Ávila R; Spriggs S; Gilmour N
    Crit Rev Toxicol; 2024 Feb; 54(2):69-91. PubMed ID: 38385441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacing the refinement for skin sensitization testing: Considerations to the implementation of adverse outcome pathway (AOP)-based defined approaches (DA) in OECD guidelines.
    Kolle SN; Landsiedel R; Natsch A
    Regul Toxicol Pharmacol; 2020 Aug; 115():104713. PubMed ID: 32562760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of AOP networks for reproductive and developmental toxicity assay development.
    Knapen D; Vergauwen L; Villeneuve DL; Ankley GT
    Reprod Toxicol; 2015 Aug; 56():52-5. PubMed ID: 25889759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing skin sensitization hazard in mice and men using non-animal test methods.
    Urbisch D; Mehling A; Guth K; Ramirez T; Honarvar N; Kolle S; Landsiedel R; Jaworska J; Kern PS; Gerberick F; Natsch A; Emter R; Ashikaga T; Miyazawa M; Sakaguchi H
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):337-51. PubMed ID: 25541156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer learning for predicting human skin sensitizers.
    Tung CW; Lin YH; Wang SS
    Arch Toxicol; 2019 Apr; 93(4):931-940. PubMed ID: 30806762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-animal methods to predict skin sensitization (II): an assessment of defined approaches
    Kleinstreuer NC; Hoffmann S; Alépée N; Allen D; Ashikaga T; Casey W; Clouet E; Cluzel M; Desprez B; Gellatly N; Göbel C; Kern PS; Klaric M; Kühnl J; Martinozzi-Teissier S; Mewes K; Miyazawa M; Strickland J; van Vliet E; Zang Q; Petersohn D
    Crit Rev Toxicol; 2018 May; 48(5):359-374. PubMed ID: 29474122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.